Australie - anglais - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - mycophenolate mofetil, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; hyprolose; purified talc; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400; indigo carmine aluminium lake - prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. prophylaxis of organ rejection in paediatric patients (with a body surface area > 1.5 m2) receiving allogeneic renal transplants.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mycophenolate mofetil, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; hyprolose; povidone; purified talc; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400; indigo carmine aluminium lake - prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. prophylaxis of organ rejection in paediatric patients (with a body surface area > 1.5 m2) receiving allogeneic renal transplants.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - mycophenolate mofetil, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; hyprolose; povidone; purified talc; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400; indigo carmine aluminium lake - prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. prophylaxis of organ rejection in paediatric patients (with a body surface area > 1.5 m2) receiving allogeneic renal transplants.

Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mycophenolate mofetil 500 mg - powder for concentrate for solution for infusion - 500 mg - mycophenolate mofetil 500 mg - mycophenolic acid

Irlande - anglais - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid

Irlande - anglais - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid

Irlande - anglais - HPRA (Health Products Regulatory Authority)

accord healthcare limited - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid

Irlande - anglais - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid

Irlande - anglais - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid

Australie - anglais - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mycophenolate mofetil, quantity: 250 mg - capsule - excipient ingredients: croscarmellose sodium; magnesium stearate; indigo carmine; purified water; titanium dioxide; gelatin; iron oxide red; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - mycophenolate mofetil is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,mycophenolate mofetil is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.